New Bill Would Perpetuate FDA-State Compounding Confusion

By Greg Ryan (October 1, 2013, 9:47 PM EDT) -- A bill aimed at revamping the regulation of compounded drugs is poised to sail through Congress, but attorneys say that by allowing manufacturers to decide whether they want to be overseen by federal or state authorities, the bill fails to clear up the very confusion that prompted its creation.

The legislation, unveiled last week, comes after nearly a year of wrangling in Washington over the best way to strengthen the oversight of compounding pharmacies in the wake of a deadly meningitis outbreak in October 2012. At least 750 people were sickened and 64 killed as a result of being injected with...

Stay ahead of the curve

In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.

  • Access to case data within articles (numbers, filings, courts, nature of suit, and more.)
  • Access to attached documents such as briefs, petitions, complaints, decisions, motions, etc.
  • Create custom alerts for specific article and case topics and so much more!


Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Ask a question!